Laurent Baranzelli

AURIMOD is a 2015 founded start-up launched by a highly experienced and interdisciplinary team from academia, medicine and engineering. We focus on product development and applied biomedical/clinical research in the field of wearable electro-medical devices for percutaneous auricular vagus nerve stimulation. We develop innovative therapies for personalized pain management based on electrical stimulation. The targeted stimulation modulates sensory fibers of the vagus nerve in the ear. This minimal-invasive pain therapy has successfully been proven its clinical efficacy and effectiveness. Auricular vagus nerve stimulation is a non-pharmacological pain treatment with sustainable effects. Our highly innovative concept of stimulation allows for an optimized and individual therapy even for otherwise treatment resistant patients.

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com

AURIMOD is a 2015 founded start-up launched by a highly experienced and interdisciplinary team from academia, medicine and engineering. We focus on product development and applied biomedical/clinical research in the field of wearable electro-medical devices for percutaneous auricular vagus nerve stimulation. We develop innovative therapies for personalized pain management based on electrical stimulation. The targeted stimulation modulates sensory fibers of the vagus nerve in the ear. This minimal-invasive pain therapy has successfully been proven its clinical efficacy and effectiveness. Auricular vagus nerve stimulation is a non-pharmacological pain treatment with sustainable effects. Our highly innovative concept of stimulation allows for an optimized and individual therapy even for otherwise treatment resistant patients.

Touchdown Neurotech is revolutionising neuromodulation market access for North American companies in Europe. Combining over 25 years of knowledge, we know exactly what it takes to turn innovative healthcare and wellness products into commercially exciting opportunities. Were dedicated to serving select North American neurotechnology and neuromodulation companies to introduce and build their commercial footprint in the UK, Europe, and other international territories. We believe in taking actionable responsibility for the success of your product outside of the United States. Our mission is to change what we see as an outdated and ineffective market access service. Our founders have spent the last 10 years working for start-up and scale-up organisations, being accountable for the commercial success of multiple neuromodulation devices. We have seen first-hand how frustrating it can be working with ineffective agencies when boots on the ground and individuals acting on executing the work are what is required. Partnering with Touchdown Neurotech gives you immediate access to our founders and their network of neurotech professionals, seamlessly extending your core team and allowing you to quickly and effectively expand into new key territories. We understand how hard commercialising medical technologies can be, so let Touchdown Neurotech be your guide and executor to de-risk the process and allow you to achieve commercial success.

Bioventus®Inc. (Nasdaq: BVS) develops Innovations for Active Healing and its mission is to make a difference by helping patients resume and enjoy active lives. The Company has products focused in three vertical markets: pain treatment, restorative therapies and surgical solutions. Established in 2012, Bioventus is headquartered in Durham, NC. The company has more than 1,200 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN, Farmindale, NY, Valencia, CA, Hod Hasharon, Israel and Mississauga, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world. Visit www.Bioventus.com and find us on Twitter @bioventusglobal.

Entrepreneurship in the service of the climate emergency! We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases. Our mission: > identify high-impact innovations; > recruit experienced entrepreneurs to transform these innovations into companies with solid business models; > inject financial resources to maximize and accelerate deployment. All innovations are made available as open source. Every euro raised is used to combat climate change. Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change. Everything is detailed (and you can contact us) at team-planet.com

Kurage is a French company active in the field of AI and motor handicap treatment. It has developed Neuroskin, an AI-powered neuromuscular electrostimulation device that is transforming the field of acquired neuromotor handicap rehabilitation., by restoring the disabled functions of the central nervous system. Kurage’s mission is to restore mobility for those in need, and drive societal change by enhancing the quality of life of individuals with neurological impairments through innovative technologies and solutions.